Table 4.
Scale | <50 years | ≥50 Years | Overall | |||
---|---|---|---|---|---|---|
| ||||||
β | p-value | β | p-value | β | p-value | |
VFQ Composite | −2.79 | <0.0001 | −3.82 | <0.0001 | −3.27 | <0.0001 |
SF-36 GHPI | −4.66 | 0.0001 | −2.98 | 0.03 | −3.92 | <0.0001 |
SF-36 MCS | −1.65 | 0.006 | −1.63 | 0.01 | −1.67 | 0.0001 |
SF-36 PCS | −1.32 | 0.01 | −1.73 | 0.01 | −1.50 | 0.0005 |
CES-D 16+ | ||||||
No symptoms | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | |||
Dry eye symptoms | 1.53 (1.03, 2.29) | 1.81 (1.19, 2.77) | 1.64 (1.23, 2.19) |
VFQ= National Eye Institute Visual Functioning Questionnaire, GHPI= General Health Perception Index, MCS= Mental Component Score, PCS= Physical Component Score, CES-D= Center for Epidemiologic Studies-Depression Scale
Presented as mean difference in score (dry eye symptom positive-dry eye symptom negative), and p-value; except for CES-D presented as odds of a score greater than or equal to 16 (indicating depression) for those with dry eye symptoms versus those without and 95% Confidence Interval.
All estimates controlling for age, sex, education, CVD, diabetes, severe headaches or migraines, arthritis, cancer, hypertension, asthma, thyroid disease, diabetic retinopathy, age-related macular degeneration, retinal detachment, cataract, and glaucoma.